Analysis of prognostic markers in serous ovarian cancer following neoadjuvant chemotherapy

被引：0
|
作者：
Mathur, S. R. [1 ]
Khandakar, B. [1 ]
Kumar, L. [2 ]
Kumar, S. [3 ]
Iyer, V. K. [1 ]
Gupta, S. Datta [1 ]
机构：
[1] AIIMS, Dept Pathol, New Delhi, India
[2] AIIMS, Dept Med Oncol, New Delhi, India
[3] AIIMS, Dept Obstet & Gynaecol, New Delhi, India
来源：
HISTOPATHOLOGY | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
306
引用
收藏
页码：106 / 107
页数：2
相关论文
共 50 条
  • [41] PROGNOSTIC ROLE OF PATHOLOGICAL CHEMOTHERAPY RESPONSE SCORE IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER
    Setton, Ariella Jakobson
    Levin, Gabriel
    Raban, Oded
    Sabah, Gad
    Tsoref, Daliah
    From, Anat
    Perri, Tamar
    Eitan, Ram
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A142 - A143
  • [42] PROGNOSTIC SIGNIFICANCE OF CYSTOSCOPY FINDINGS FOLLOWING NEOADJUVANT CHEMOTHERAPY FOR MUSCLEINVASIVE BLADDER CANCER
    Mansour, Ahmed M.
    Singal, Rakesh
    Eldefrawy, Ahmed
    Joshi, Shivam
    Soloway, Mark S.
    Manoharan, Murugesan
    JOURNAL OF UROLOGY, 2012, 187 (04): : E705 - E705
  • [43] The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer
    Grova, Monica M.
    Strassle, Paula D.
    Navajas, Emma E.
    Gallagher, Kristalyn K.
    Ollila, David W.
    Downs-Canner, Stephanie M.
    Spanheimer, Philip M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (04) : 2182 - 2190
  • [44] POLY-(ADP-RIBOSE)-GLYCOHYDROLASE LOCALIZES TO THE CYTOPLASM FOLLOWING NEOADJUVANT CHEMOTHERAPY IN OVARIAN SEROUS CARCINOMA
    Knigin, David
    Yang, Bo Wen
    Matanes, Emad
    Yasmeen, Amber
    Gotlieb, Walter
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A149 - A150
  • [45] The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer
    Monica M. Grova
    Paula D. Strassle
    Emma E. Navajas
    Kristalyn K. Gallagher
    David W. Ollila
    Stephanie M. Downs-Canner
    Philip M. Spanheimer
    Annals of Surgical Oncology, 2021, 28 : 2182 - 2190
  • [46] Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancer
    Surrin S. Deen
    Andrew N. Priest
    Mary A. McLean
    Andrew B. Gill
    Cara Brodie
    Robin Crawford
    John Latimer
    Peter Baldwin
    Helena M. Earl
    Christine Parkinson
    Sarah Smith
    Charlotte Hodgkin
    Ilse Patterson
    Helen Addley
    Susan Freeman
    Penny Moyle
    Mercedes Jimenez-Linan
    Martin J. Graves
    Evis Sala
    James D. Brenton
    Ferdia A. Gallagher
    Scientific Reports, 9
  • [47] Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancer
    Deen, Surrin S.
    Priest, Andrew N.
    McLean, Mary A.
    Gill, Andrew B.
    Brodie, Cara
    Crawford, Robin
    Latimer, John
    Baldwin, Peter
    Earl, Helena M.
    Parkinson, Christine
    Smith, Sarah
    Hodgkin, Charlotte
    Patterson, Ilse
    Addley, Helen
    Freeman, Susan
    Moyle, Penny
    Jimenez-Linan, Mercedes
    Graves, Martin J.
    Sala, Evis
    Brenton, James D.
    Gallagher, Ferdia A.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [48] Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
    Lee, Yong Jae
    Woo, Ha Young
    Kim, Yoo-Na
    Park, Junsik
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    Park, Eunhyang
    Joung, Je-Gun
    Lee, Jung-Yun
    CANCERS, 2022, 14 (09)
  • [49] Transcriptomic profiles of response to neoadjuvant chemotherapy in patients with high-grade serous ovarian cancer.
    Lee, Sanghoon
    Zhao, Li
    Fleming, Nicole D.
    Celestino, Joseph
    Hajek, Richard A.
    Morgan, Margaret B.
    Liu, Yan
    Westin, Shannon N.
    Jazaeri, Amir A.
    Liu, Jinsong
    Zhang, Jianhua
    Futreal, P. Andrew
    Sood, Anil K.
    CANCER RESEARCH, 2022, 82 (12)
  • [50] Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
    Dhiman, Pravesh
    Bapsy, P. P.
    Patil, C. N.
    Raghupathi, Renu
    SOUTH ASIAN JOURNAL OF CANCER, 2022, 11 (03) : 207 - 212
12345